Showing results (61-70 of 145) with videos related to

Sort By:
Pageof 15
Therapeutic Advances in Medical Oncology|December 19, 2024
Sex differences in patients with Non-Small Cell Lung Cancer harboring driver fusions treated with tyrosine kinase inhibitors: a systematic reviewRita Leporati, Édouard Auclin, Daniel Morchón, et al.
Lung Cancer (Amsterdam, Netherlands)|December 27, 2011
Trabectedin in patients with advanced non-small-cell lung cancer (NSCLC) with XPG and/or ERCC1 overexpression and BRCA1 underexpression and pretreated with platinumBartomeu Massuti, Manuel Cobo, Carlos Camps, et al.
Clinical Nutrition (Edinburgh, Scotland)|June 15, 2021
GLIM vs ESPEN criteria for the diagnosis of early malnutrition in oncological outpatientsMarta Gascón-Ruiz, Diego Casas-Deza, Irene Torres-Ramón, et al.
European Journal of Clinical Nutrition|October 8, 2021
Comparation of different malnutrition screening tools according to GLIM criteria in cancer outpatientsMarta Gascón-Ruiz, Diego Casas-Deza, Irene Torres-Ramón, et al.
Biomedicines|September 23, 2022
Diagnosis of Malnutrition According to GLIM Criteria Predicts Complications and 6-Month Survival in Cancer OutpatientsMarta Gascón-Ruiz, Diego Casas-Deza, Maria Marti-Pi, et al.
Oncoimmunology|July 11, 2022
PD-1 is expressed in cytotoxic granules of NK cells and rapidly mobilized to the cell membrane following recognition of tumor cellsCecilia Pesini, Sandra Hidalgo, Maykel A Arias, et al.
Cells|June 26, 2020
Intratumoral Versus Circulating Lymphoid Cells as Predictive Biomarkers in Lung Cancer Patients Treated with Immune Checkpoint Inhibitors: Is the Easiest Path the Best One?Marta Gascón, Dolores Isla, Mara Cruellas, et al.
Archivos De Bronconeumologia|April 19, 2017
Reflections on the Implementation of Low-Dose Computed Tomography Screening in Individuals at High Risk of Lung Cancer in SpainPilar Garrido, Marcelo Sánchez, José Belda Sanchis, et al.
Lung Cancer (Amsterdam, Netherlands)|June 20, 2017
A phase Ib trial of continuous once-daily oral afatinib plus sirolimus in patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer and/or disease progression following prior erlotinib or gefitinibTeresa Moran, Ramón Palmero, Mariano Provencio, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 29, 2012
Functions and workload of medical oncologists in SpainCristina Grávalos, Javier Salvador, Joan Albanell, et al.
Pageof 15